questionsmedicales.fr
Composés chimiques organiques
Composés du soufre
Sulfones
Sulfonamides
Sulfonamides : Questions médicales fréquentes
Termes MeSH sélectionnés :
Angiotensin-Converting Enzyme 2
Diagnostic
5
Infections bactériennes
Diagnostic médical
Sensibilité aux antibiotiques
Tests de laboratoire
Résistance bactérienne
Antibiotiques
Symptômes
Infections bactériennes
Infection urinaire
Culture bactérienne
Symptômes
5
Symptômes
Infections bactériennes
Effets secondaires
Réactions allergiques
Allergies médicamenteuses
Eruptions cutanées
Troubles gastro-intestinaux
Effets secondaires
Prévention
5
Prévention des infections
Hygiène
Prophylaxie
Antibiotiques
Hygiène
Prévention des infections
Vaccination
Prévention des infections
Résistance aux antibiotiques
Utilisation des médicaments
Traitements
5
Administration médicamenteuse
Antibiotiques
Thérapie combinée
Antibiotiques
Suivi médical
Effets secondaires
Infections virales
Antibiotiques
Complications
5
Complications
Effets secondaires
Réactions allergiques
Urgences médicales
Troubles rénaux
Effets secondaires
Interactions médicamenteuses
Effets secondaires
Facteurs de risque
5
Facteurs de risque
Allergies médicamenteuses
Personnes âgées
Effets secondaires
Maladies hépatiques
Effets secondaires
Infections récurrentes
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sulfonamides : Questions médicales les plus fréquentes",
"headline": "Sulfonamides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sulfonamides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-25",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sulfonamides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sulfones",
"url": "https://questionsmedicales.fr/mesh/D013450",
"about": {
"@type": "MedicalCondition",
"name": "Sulfones",
"code": {
"@type": "MedicalCode",
"code": "D013450",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bumétanide",
"alternateName": "Bumetanide",
"url": "https://questionsmedicales.fr/mesh/D002034",
"about": {
"@type": "MedicalCondition",
"name": "Bumétanide",
"code": {
"@type": "MedicalCode",
"code": "D002034",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diclofénamide",
"alternateName": "Dichlorphenamide",
"url": "https://questionsmedicales.fr/mesh/D004005",
"about": {
"@type": "MedicalCondition",
"name": "Diclofénamide",
"code": {
"@type": "MedicalCode",
"code": "D004005",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.410"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mafénide",
"alternateName": "Mafenide",
"url": "https://questionsmedicales.fr/mesh/D008272",
"about": {
"@type": "MedicalCondition",
"name": "Mafénide",
"code": {
"@type": "MedicalCode",
"code": "D008272",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.570"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Méfruside",
"alternateName": "Mefruside",
"url": "https://questionsmedicales.fr/mesh/D008529",
"about": {
"@type": "MedicalCondition",
"name": "Méfruside",
"code": {
"@type": "MedicalCode",
"code": "D008529",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.575"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Probénécide",
"alternateName": "Probenecid",
"url": "https://questionsmedicales.fr/mesh/D011339",
"about": {
"@type": "MedicalCondition",
"name": "Probénécide",
"code": {
"@type": "MedicalCode",
"code": "D011339",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfamides",
"alternateName": "Sulfanilamides",
"url": "https://questionsmedicales.fr/mesh/D013424",
"about": {
"@type": "MedicalCondition",
"name": "Sulfamides",
"code": {
"@type": "MedicalCode",
"code": "D013424",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Furosémide",
"alternateName": "Furosemide",
"url": "https://questionsmedicales.fr/mesh/D005665",
"about": {
"@type": "MedicalCondition",
"name": "Furosémide",
"code": {
"@type": "MedicalCode",
"code": "D005665",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfacétamide",
"alternateName": "Sulfacetamide",
"url": "https://questionsmedicales.fr/mesh/D013409",
"about": {
"@type": "MedicalCondition",
"name": "Sulfacétamide",
"code": {
"@type": "MedicalCode",
"code": "D013409",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfachlorpyridazine",
"alternateName": "Sulfachlorpyridazine",
"url": "https://questionsmedicales.fr/mesh/D013410",
"about": {
"@type": "MedicalCondition",
"name": "Sulfachlorpyridazine",
"code": {
"@type": "MedicalCode",
"code": "D013410",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfadiazine",
"alternateName": "Sulfadiazine",
"url": "https://questionsmedicales.fr/mesh/D013411",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadiazine",
"code": {
"@type": "MedicalCode",
"code": "D013411",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.755"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sulfadiazine d'argent",
"alternateName": "Silver Sulfadiazine",
"url": "https://questionsmedicales.fr/mesh/D012837",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadiazine d'argent",
"code": {
"@type": "MedicalCode",
"code": "D012837",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.755.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sulfadiazine d'argent",
"alternateName": "Silver Sulfadiazine",
"url": "https://questionsmedicales.fr/mesh/D012837",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadiazine d'argent",
"code": {
"@type": "MedicalCode",
"code": "D012837",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.755.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfadiméthoxine",
"alternateName": "Sulfadimethoxine",
"url": "https://questionsmedicales.fr/mesh/D013412",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadiméthoxine",
"code": {
"@type": "MedicalCode",
"code": "D013412",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfadoxine",
"alternateName": "Sulfadoxine",
"url": "https://questionsmedicales.fr/mesh/D013413",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadoxine",
"code": {
"@type": "MedicalCode",
"code": "D013413",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.765"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfaguanidine",
"alternateName": "Sulfaguanidine",
"url": "https://questionsmedicales.fr/mesh/D013414",
"about": {
"@type": "MedicalCondition",
"name": "Sulfaguanidine",
"code": {
"@type": "MedicalCode",
"code": "D013414",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.810"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfalène",
"alternateName": "Sulfalene",
"url": "https://questionsmedicales.fr/mesh/D013415",
"about": {
"@type": "MedicalCondition",
"name": "Sulfalène",
"code": {
"@type": "MedicalCode",
"code": "D013415",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.850"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfamérazine",
"alternateName": "Sulfamerazine",
"url": "https://questionsmedicales.fr/mesh/D013416",
"about": {
"@type": "MedicalCondition",
"name": "Sulfamérazine",
"code": {
"@type": "MedicalCode",
"code": "D013416",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.853"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfamétoxydiazine",
"alternateName": "Sulfameter",
"url": "https://questionsmedicales.fr/mesh/D013417",
"about": {
"@type": "MedicalCondition",
"name": "Sulfamétoxydiazine",
"code": {
"@type": "MedicalCode",
"code": "D013417",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.857"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfadimidine",
"alternateName": "Sulfamethazine",
"url": "https://questionsmedicales.fr/mesh/D013418",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadimidine",
"code": {
"@type": "MedicalCode",
"code": "D013418",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.862"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfaméthoxazole",
"alternateName": "Sulfamethoxazole",
"url": "https://questionsmedicales.fr/mesh/D013420",
"about": {
"@type": "MedicalCondition",
"name": "Sulfaméthoxazole",
"code": {
"@type": "MedicalCode",
"code": "D013420",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.867"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfaméthoxypyridazine",
"alternateName": "Sulfamethoxypyridazine",
"url": "https://questionsmedicales.fr/mesh/D013421",
"about": {
"@type": "MedicalCondition",
"name": "Sulfaméthoxypyridazine",
"code": {
"@type": "MedicalCode",
"code": "D013421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.872"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfamonométhoxine",
"alternateName": "Sulfamonomethoxine",
"url": "https://questionsmedicales.fr/mesh/D013422",
"about": {
"@type": "MedicalCondition",
"name": "Sulfamonométhoxine",
"code": {
"@type": "MedicalCode",
"code": "D013422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.877"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfamoxole",
"alternateName": "Sulfamoxole",
"url": "https://questionsmedicales.fr/mesh/D013423",
"about": {
"@type": "MedicalCondition",
"name": "Sulfamoxole",
"code": {
"@type": "MedicalCode",
"code": "D013423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.882"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfanilamide",
"alternateName": "Sulfanilamide",
"url": "https://questionsmedicales.fr/mesh/D000077145",
"about": {
"@type": "MedicalCondition",
"name": "Sulfanilamide",
"code": {
"@type": "MedicalCode",
"code": "D000077145",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.885"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfapyridine",
"alternateName": "Sulfapyridine",
"url": "https://questionsmedicales.fr/mesh/D013427",
"about": {
"@type": "MedicalCondition",
"name": "Sulfapyridine",
"code": {
"@type": "MedicalCode",
"code": "D013427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.900"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfaquinoxaline",
"alternateName": "Sulfaquinoxaline",
"url": "https://questionsmedicales.fr/mesh/D013428",
"about": {
"@type": "MedicalCondition",
"name": "Sulfaquinoxaline",
"code": {
"@type": "MedicalCode",
"code": "D013428",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.925"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfaméthizol",
"alternateName": "Sulfamethizole",
"url": "https://questionsmedicales.fr/mesh/D013419",
"about": {
"@type": "MedicalCondition",
"name": "Sulfaméthizol",
"code": {
"@type": "MedicalCode",
"code": "D013419",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.935.813"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfisomidine",
"alternateName": "Sulfisomidine",
"url": "https://questionsmedicales.fr/mesh/D013443",
"about": {
"@type": "MedicalCondition",
"name": "Sulfisomidine",
"code": {
"@type": "MedicalCode",
"code": "D013443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.940"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfafurazol",
"alternateName": "Sulfisoxazole",
"url": "https://questionsmedicales.fr/mesh/D013444",
"about": {
"@type": "MedicalCondition",
"name": "Sulfafurazol",
"code": {
"@type": "MedicalCode",
"code": "D013444",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.945"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sulfasalazine",
"alternateName": "Sulfasalazine",
"url": "https://questionsmedicales.fr/mesh/D012460",
"about": {
"@type": "MedicalCondition",
"name": "Sulfasalazine",
"code": {
"@type": "MedicalCode",
"code": "D012460",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.730"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tamsulosine",
"alternateName": "Tamsulosin",
"url": "https://questionsmedicales.fr/mesh/D000077409",
"about": {
"@type": "MedicalCondition",
"name": "Tamsulosine",
"code": {
"@type": "MedicalCode",
"code": "D000077409",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.863"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Xipamide",
"alternateName": "Xipamide",
"url": "https://questionsmedicales.fr/mesh/D014988",
"about": {
"@type": "MedicalCondition",
"name": "Xipamide",
"code": {
"@type": "MedicalCode",
"code": "D014988",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.975"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Sulfonamides",
"alternateName": "Sulfonamides",
"code": {
"@type": "MedicalCode",
"code": "D013449",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Reihane Ghomashi",
"url": "https://questionsmedicales.fr/author/Reihane%20Ghomashi",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran."
}
},
{
"@type": "Person",
"name": "Shakila Ghomashi",
"url": "https://questionsmedicales.fr/author/Shakila%20Ghomashi",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran."
}
},
{
"@type": "Person",
"name": "Hamidreza Aghaei",
"url": "https://questionsmedicales.fr/author/Hamidreza%20Aghaei",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran."
}
},
{
"@type": "Person",
"name": "Ahmad Reza Massah",
"url": "https://questionsmedicales.fr/author/Ahmad%20Reza%20Massah",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran."
}
},
{
"@type": "Person",
"name": "Satoru Suzuki",
"url": "https://questionsmedicales.fr/author/Satoru%20Suzuki",
"affiliation": {
"@type": "Organization",
"name": "Leading Academia in Marine and Environment Pollution Research (LaMer), Center for Marine Environmental Studies (CMES), Ehime University, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36787743",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cell.2023.01.039"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of spike proteins on angiotensin converting enzyme 2 (ACE2).",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37769892",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.abb.2023.109769"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients.",
"datePublished": "2023-04-14",
"url": "https://questionsmedicales.fr/article/37060024",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40360-023-00667-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum levels of angiotensin-converting enzyme 2 in children with Kawasaki disease.",
"datePublished": "2022-11-07",
"url": "https://questionsmedicales.fr/article/36344782",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10238-022-00933-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Angiotensin-Converting Enzyme 2 (ACE2) Gene Polymorphism in Patients with Type 2 Diabetes (",
"datePublished": "2022-12-31",
"url": "https://questionsmedicales.fr/article/37274884",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.22092/ARI.2022.358736.2294"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés du soufre",
"item": "https://questionsmedicales.fr/mesh/D013457"
},
{
"@type": "ListItem",
"position": 4,
"name": "Sulfones",
"item": "https://questionsmedicales.fr/mesh/D013450"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sulfonamides",
"item": "https://questionsmedicales.fr/mesh/D013449"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sulfonamides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sulfonamides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sulfonamides",
"description": "Comment diagnostiquer une infection nécessitant des sulfonamides ?\nQuels tests sont utilisés pour évaluer l'efficacité des sulfonamides ?\nLes sulfonamides sont-ils efficaces contre toutes les bactéries ?\nQuels signes cliniques indiquent une infection bactérienne ?\nComment confirmer une infection urinaire ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Angiotensin-Converting+Enzyme+2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sulfonamides",
"description": "Quels sont les symptômes d'une infection traitée par sulfonamides ?\nLes sulfonamides provoquent-ils des effets secondaires ?\nComment reconnaître une réaction allergique aux sulfonamides ?\nQuels symptômes indiquent une surinfection ?\nLes sulfonamides peuvent-ils causer des troubles gastro-intestinaux ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Angiotensin-Converting+Enzyme+2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sulfonamides",
"description": "Comment prévenir les infections nécessitant des sulfonamides ?\nLes sulfonamides peuvent-ils être utilisés en prophylaxie ?\nQuelles mesures d'hygiène sont recommandées ?\nLes vaccinations aident-elles à prévenir les infections ?\nComment éviter la résistance aux antibiotiques ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Angiotensin-Converting+Enzyme+2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sulfonamides",
"description": "Comment les sulfonamides sont-ils administrés ?\nQuelle est la posologie habituelle des sulfonamides ?\nLes sulfonamides peuvent-ils être combinés avec d'autres antibiotiques ?\nQuel suivi est nécessaire lors d'un traitement par sulfonamides ?\nLes sulfonamides sont-ils efficaces contre les infections virales ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Angiotensin-Converting+Enzyme+2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sulfonamides",
"description": "Quelles complications peuvent survenir avec les sulfonamides ?\nComment gérer une réaction allergique sévère aux sulfonamides ?\nLes sulfonamides peuvent-ils causer des troubles rénaux ?\nQuels signes indiquent une complication grave ?\nLes sulfonamides peuvent-ils interagir avec d'autres médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Angiotensin-Converting+Enzyme+2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sulfonamides",
"description": "Qui est à risque de développer des effets secondaires aux sulfonamides ?\nLes personnes âgées sont-elles plus à risque avec les sulfonamides ?\nLes femmes enceintes peuvent-elles prendre des sulfonamides ?\nLes patients atteints de maladies hépatiques sont-ils à risque ?\nLes antécédents d'infections récurrentes augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Angiotensin-Converting+Enzyme+2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection nécessitant des sulfonamides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur des symptômes cliniques et des cultures bactériennes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'efficacité des sulfonamides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de sensibilité aux antibiotiques sont réalisés sur des échantillons microbiologiques."
}
},
{
"@type": "Question",
"name": "Les sulfonamides sont-ils efficaces contre toutes les bactéries ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité varie selon le type de bactérie et leur résistance."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une infection bactérienne ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur, rougeur et gonflement peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment confirmer une infection urinaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen d'urine et une culture permettent de confirmer une infection urinaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection traitée par sulfonamides ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur, fatigue et symptômes locaux selon l'infection."
}
},
{
"@type": "Question",
"name": "Les sulfonamides provoquent-ils des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets comme éruptions cutanées, nausées ou réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux sulfonamides ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éruptions cutanées, démangeaisons, ou gonflement peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surinfection ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Augmentation de la douleur, fièvre persistante et écoulement purulent peuvent indiquer une surinfection."
}
},
{
"@type": "Question",
"name": "Les sulfonamides peuvent-ils causer des troubles gastro-intestinaux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des nausées, vomissements ou diarrhées peuvent survenir avec leur utilisation."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections nécessitant des sulfonamides ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène, se faire vacciner et éviter les contacts avec des malades."
}
},
{
"@type": "Question",
"name": "Les sulfonamides peuvent-ils être utilisés en prophylaxie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être prescrits en prophylaxie pour prévenir certaines infections."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le partage d'objets personnels."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque d'infections bactériennes."
}
},
{
"@type": "Question",
"name": "Comment éviter la résistance aux antibiotiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser les antibiotiques uniquement lorsque prescrit et suivre les recommandations médicales."
}
},
{
"@type": "Question",
"name": "Comment les sulfonamides sont-ils administrés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement administrés par voie orale ou intraveineuse selon l'infection."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie habituelle des sulfonamides ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie selon l'infection, mais doit être prescrite par un médecin."
}
},
{
"@type": "Question",
"name": "Les sulfonamides peuvent-ils être combinés avec d'autres antibiotiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés en association pour élargir le spectre d'action."
}
},
{
"@type": "Question",
"name": "Quel suivi est nécessaire lors d'un traitement par sulfonamides ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier pour surveiller les effets secondaires et l'efficacité est recommandé."
}
},
{
"@type": "Question",
"name": "Les sulfonamides sont-ils efficaces contre les infections virales ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les sulfonamides ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les sulfonamides ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques graves, des troubles sanguins ou des lésions hépatiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique sévère aux sulfonamides ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cesser immédiatement le traitement et consulter un médecin pour un traitement approprié."
}
},
{
"@type": "Question",
"name": "Les sulfonamides peuvent-ils causer des troubles rénaux ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles rénaux peuvent survenir, nécessitant une surveillance de la fonction rénale."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre élevée, éruption cutanée étendue ou difficulté respiratoire peuvent indiquer une complication."
}
},
{
"@type": "Question",
"name": "Les sulfonamides peuvent-ils interagir avec d'autres médicaments ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent interagir avec d'autres médicaments, augmentant le risque d'effets secondaires."
}
},
{
"@type": "Question",
"name": "Qui est à risque de développer des effets secondaires aux sulfonamides ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'allergies médicamenteuses sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque avec les sulfonamides ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru d'effets secondaires et de complications."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles prendre des sulfonamides ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation doit être évitée, car elle peut affecter le fœtus. Consultez un médecin."
}
},
{
"@type": "Question",
"name": "Les patients atteints de maladies hépatiques sont-ils à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent avoir un risque accru d'effets indésirables et nécessitent une surveillance."
}
},
{
"@type": "Question",
"name": "Les antécédents d'infections récurrentes augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents d'infections récurrentes peuvent nécessiter un traitement plus agressif."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 19/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran.
Publications dans "Sulfonamides" :
3 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran.
Publications dans "Sulfonamides" :
3 publications dans cette catégorie
Affiliations :
Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran.
Publications dans "Sulfonamides" :
3 publications dans cette catégorie
Affiliations :
Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran.
Razi Chemistry Research Center (RCRC), Shahreza Branch, Islamic Azad University, Isfahan, Iran.
Publications dans "Sulfonamides" :
3 publications dans cette catégorie
Affiliations :
Leading Academia in Marine and Environment Pollution Research (LaMer), Center for Marine Environmental Studies (CMES), Ehime University, Japan.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China; School of Life Science, Jinggangshan University, Ji'an 343009, China.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
School of Life Science, Jinggangshan University, Ji'an 343009, China.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
School of Life Science, Jinggangshan University, Ji'an 343009, China. Electronic address: zouxming_80@hotmail.com.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
Section of Pharmaceutical and Nutraceutical Sciences, Department of Neurofarba, University of Florence, Via U. Schiff 6, 50019 Sesto Fiorentino (Florence), Italy.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
Section of Pharmaceutical and Nutraceutical Sciences, Department of Neurofarba, University of Florence, Via U. Schiff 6, 50019 Sesto Fiorentino (Florence), Italy.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
Section of Pharmaceutical and Nutraceutical Sciences, Department of Neurofarba, University of Florence, Via U. Schiff 6, 50019 Sesto Fiorentino (Florence), Italy.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
Institute of Biosciences and Bioresources, CNR, Via Pietro Castellino 111, 80131 Napoli, Italy.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Ecological Pest Control for Fujian and Taiwan Crops, College of Plant Protection, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory for Analytical Science of Food Safety and Biology of MOE, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan.
Publications dans "Sulfonamides" :
2 publications dans cette catégorie
Affiliations :
Center for Marine Environmental Studies, Ehime University, Matsuyama, Ehime, 790-8577, Japan.
Publications dans "Sulfonamides" :
1 publication dans cette catégorie
Affiliations :
Department of Organic Chemistry and Biochemistry, Clemens-Schöpf-Institute, Technical University Darmstadt, Alarich-Weiss-Straße 4, 64287 Darmstadt, Germany.
Publications dans "Sulfonamides" :
ACE2 is the indispensable entry receptor for SARS-CoV and SARS-CoV-2. Because of the COVID-19 pandemic, it has become one of the most therapeutically targeted human molecules in biomedicine. ACE2 serv...
The Coronavirus Disease 2019 (COVID-19) pandemic was caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which enters host cells through interactions of its spike protein to Angiot...
Renin-angiotensin-aldosterone system (RAAS) is hypothesized to be in the center of COVID pathophysiology as the angiotensin converting enzyme 2 (ACE2) represents the main entrance of the virus, thus t...
A total of 40 healthy controls and 60 Egyptian patients suffering from chronic cardiovascular diseases were enrolled in this study. Patients were divided into 40 patients treated with ACEIs and 20 pat...
Assessment of serum ACE2 level in different groups showed a significant difference between ACEIs and healthy groups and ACEIs and ARBs group, while there was no difference between ARBs and healthy. Mu...
ACE2 levels varied between ACEIs and ARBs. It tends to be lower in ACEIs group and there is a strong positive association between ACE2 level and the female sex. This needs to be considered in Future s...
Retrospectively registered ClinicalTrials.gov ID: NCT05418361 (June 2022)....
Kawasaki disease (KD) has replaced rheumatic fever as the main cause of acquired heart disease in Japanese, American, and Chinese children. Polymorphisms in angiotensin-converting enzyme may be associ...
The increased levels of blood glucose associated with genetic and/or environmental risk factors have been known as Type 2 diabetes mellitus (T2D). T2D is categorized as a dangerous clinical syndrome f...
Rapid and cost-effective diagnostic tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are a critical and valuable weapon for the coronavirus disease 2019 (COVID-19) pandemic respo...
In order to prevent COVID-19 from progressing, angiotensin-converting enzyme 2 (ACE2) binds to SARS-CoV-2 and prevents the virus from entering target cells. Several studies have found a correlation be...
We conducted a systematic review using PubMed, Embase, Cochrane Library, Scopus, Science Direct and Web of Science databases. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. ...
It was concluded that the ACE2 G8790A polymorphism was not associated with COVID-19 based on the data collected. Moreover, subgroup analyses stratified based on race proved that the ACE2 G allele show...
The findings indicated that the G allele of ACE2 G8790A was related to an enhanced risk of COVID-19 severity in Asians. One possible reason is that ACE2 G allele was associated with a COVID-19 cytokin...
Systemic sclerosis (SSc) is a disease with cardiovascular impairment and polymorphisms of the gene coding of angiotensin-converting-enzyme 2 (ACE2) may account for its development. Three single nucleo...
Genomic DNA was isolated from whole blood. Restriction-fragment-length polymorphism was used for genotyping of rs1978124, while detection of rs879922 and rs2285666 was based on TaqMan SNP Genotyping A...
81 SSc patients (60 women, 21 men) were enrolled. Allele C of rs879922 polymorphism was associated with significantly greater risk for development of AH (OR=2.5, p=0.018), but less frequent joint invo...
Polymorphisms of ACE2 may account for the development of AH and CVS disorders in SSc patients. Strong tendencies to more frequent occurrence of disease specific characteristics distinct to macrovascul...
The quick and advancing prevalence of the new coronavirus SARS-CoV-2 produced a global crisis surge with a profound impact on human health and worldwide economic constancy. The virus is known as one s...
The Angiotensin-Converting Enzyme 2 (ACE2) is the main receptor of the SARS-CoV-2. There is contradictory evidence on how the exposure to nicotine may module the concentration of soluble ACE2 (sACE2)....
Pooled analysis performed with data retrieved from two studies (n = 634 and n = 302). Geometric mean (GM) concentrations of sACE2, both total and relative to the total amount of protein in the sample,...
We observed a significant increase of 0.108‰ and 0.087 ng/μl in the relative and absolute salivary sACE2 GM concentrations, respectively, between the lowest and highest nicotine levels. Similar result...
Salivary nicotine concentration seems to be limitedly associated with the concentration of sACE2....